GlassScriptPrepare for your visit
Amanda Bohannon
Family · Sharonville, OH · NPI 1356723902
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,387.78
in general payments reported to CMS, 2019-2025 · $334 in 2025
The $334 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Novo Nordisk INC $246.29
- Abbvie INC. $206.80
- Exact Sciences Corporation $125.48
- Lilly USA, LLC $109.20
- Gilead Sciences, INC. $95.85
- Merck Sharp & Dohme LLC $89.81
Drugs and devices associated with these payments
Ozempic Rybelsus Cologuard Collection Kit Vraylar Mounjaro Veozah Capvaxive Gardasil 9 Trelegy Ellipta Qulipta Ubrelvy Nurtec Odt
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Amanda Bohannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10799097/amanda-bohannon